← Eichor
Study identifier: NCT04429750 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Intact Cord Resuscitation in CDH

Condition: Rare Diseases · Congenital Diaphragmatic Hernia  ·  Sponsor: University Hospital, Lille

PhaseNA
Planned participants180
Who can joinAll sexes, 36 Weeks to 37 Weeks
Healthy volunteersNo

About this study

Isolated CDH is a rare disease (1/3500) and displays a wide range of severity and outcome. Despite attempts to standardize the management of this disease at birth and during the first months of life, the mortality varies from 20 to 50% according to different hospitals in France and abroad. Several studies already showed the benefice of late cord clamping at birth on biological and physiological adaptation of newborns to life. Previous works also suggest a possible benefit of this procedure for babies with CDH. This multicenter randomized clinical study aims to investigate the efficacy of intact cord resuscitation compared to immediate cord clamping on cardiorespiratory adaptation at birth in full term newborn infants with isolated CDH.

This description comes directly from the study's public registry record.

Talk to the study team

Laurent Storme, MD,PhD  ·  03 20 44 61 99  ·  laurent.storme@chru-lille.fr

Always discuss trial participation with your own doctor first.

Locations (3)

Chu Amiens PicardieAmiens, FranceRecruiting
Hop Jeanne de Flandre Chu LilleLille, FranceRecruiting
Chu de Nantes -Nantes, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04429750